Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism

Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanismMetformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism, Published online: 19 June 2018; doi:10.1038/s41388-018-0360-7Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism

https://www.nature.com/articles/s41388-018-0360-7

Source: Oncogene - June 19, 2018 Category: Cancer & Oncology Authors: Mingzhu Bai Linlin Yang Hong Liao Xiaoyan Liang Bingying Xie Ji Xiong Xiang Tao Xiong Chen Yali Cheng Xiaojun Chen Youji Feng Zhenbo Zhang Wenxin Zheng Source Type: research